Share This Page

Alzheimer's And Dementia Weekly

Support & Insight for the Autumn of Life

Drugs:Dementia

How Many Leqembi Patients Are There?

May 5, 2025 No Comments

Alzheimer’s rates are on the rise. How is today’s best treatment, Leqembi (generic lecanemab) doing in the fight against it?

Young lady caring for elder woman with dementia

Leqembi Best at Fighting Alzheimer’s in Men

April 18, 2025 No Comments

See why Leqembi is even more effective in males than females, at fighting Alzheimer’s.

Leqembi Becomes Europe’s First Alzheimer’s Antibody

April 16, 2025 No Comments

The European Union authorizes Leqembi as its very first Alzheimer’s drug to target an underlying cause of Alzheimer’s.

Study authors David Gate (left) and Lynn van Olst (right) compare two slides containing human brain tissue. Brown amyloid beta plaques are visible in the left slide, which contains brain tissue with Alzheimer's Disease that had not been treated. The slide on the right, which contains brain tissue that had been treated, does not show amyloid plaques.

Can the New Alzheimer’s Drugs Work Even Better?

March 10, 2025 No Comments

The new Alzheimer’s antibodies, Leqembi and Kisunla, work better on some people than others. A cutting-edge technique called spatial transcriptomics may help figure out how to make them work better for everybody.

Close-up of doctor writing prescription with medicines and stethoscope on desk.

Advantages of Namzaric for Dementia

February 20, 2025 5 Comments

ARTICLE + VIDEO INFOMMERCIAL: Namazaric for dementia comes in a convenient, extended-release capsule. It conveniently combines today’s 2 most popular drugs for Alzheimer’s. Learn about easy-to-manage Namazaric.

An infusion of antibody therapy for Alzheimer's. (Courtesy of WashU Medicine news release using Getty Images)

Leqembi & Kisunla: Extending Independent Living

February 16, 2025 1 Comment

A new analysis of the benefits of these Alzheimer’s treatments scores the days and ways patients succeed in living independently.

Leqembi: Europe Checks It’s Safety; U.S. Approves Monthly Doses

February 3, 2025 No Comments

The EMA has announced its schedule for reviewing the Alzheimer’s drug Leqembi (lecanemab) for use in Europe. Meanwhile, the U.S. FDA, which already approved the drug, is moving ahead with a new version that doses Leqembi in a better, more convenient fashion for those taking the drug over the long run.

woman in white shirt holding clear plastic iv bag

What’s Ahead for Alzheimer’s Drugs in 2025

January 12, 2025 No Comments

Learn about 2025’s newly approved or potential Alzheimer’s drugs. These include Leqembi, Kisunla, Remternetug, Semaglutide, Trontinemab and Bepranemab.

Alzheimer's Amyloid Plaques choking neurons

Is Leqembi Shrinking the Alzheimer’s or the Brain?

January 5, 2025 1 Comment

Leqembi and Kisunla are the new Alzheimer’s immunotherapies. A loss of brain volume associated with these immunotherapies may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue. A new study sheds light on what’s going on.

Science Director Discussing Lecanemab (Leqembi)

Why Did Europe Finally Choose Lecanemab for Alzheimer’s?

November 28, 2024 No Comments

Europe originally said Lecanemab (Brand-name Leqembi) was too risky to approve. Now they are recommending marketing it. Why the change of heart?

Love & compassion are necessities, not luxuries. Without them, humanity cannot survive. (The Dalai Lama)

Thought of the Week: Love & Compassion

November 11, 2025

Love & compassion are necessities, not luxuries.Without them, humanity cannot survive. (The Dalai Lama)

Family eating healthy meal to prevent dementia

5 Ways Families Can Lower Alzheimer’s Risk

November 10, 2025

Families may share genes, but they can also share habits that protect the brain. Mayo Clinic experts remind us that everyday choices — not just DNA — make a powerful difference.

Bill Gates discussing Alzheimer's research on CBS Sunday Morning

Bill Gates Discusses Alzheimer’s Research on CBS Sunday Morning

November 9, 2025

In this web exclusive, Microsoft co-founder and philanthropist Bill Gates talks with CBS News chief medical correspondent Dr. Jon LaPook about research into Alzheimer’s, a disease which affected his own father.